Back to Journals » Drug Design, Development and Therapy » Volume 11

Baracle® vs Baraclude® for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety

Total article views   HTML views PDF downloads Totals
10,036 Dovepress* 8,608+ 803 9,411
PubMed Central* 1,428 204 1,632
Totals 10,036 1,007 11,043
*Since 31 October 2017

View citations on PubMed Central and Google Scholar